Cargando…

Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19

Detalles Bibliográficos
Autores principales: Chuang, Tzu-Yi, Tsai, Ming-Han, Wu, Lit-Min, Ho, Sung-Jung, Yeh, Pu-Sheng, Liu, Yi-Lien, Fred Yang, Hung-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837228/
https://www.ncbi.nlm.nih.gov/pubmed/34756359
http://dx.doi.org/10.1016/j.jmii.2020.09.007
_version_ 1783642918887620608
author Chuang, Tzu-Yi
Tsai, Ming-Han
Wu, Lit-Min
Ho, Sung-Jung
Yeh, Pu-Sheng
Liu, Yi-Lien
Fred Yang, Hung-Jen
author_facet Chuang, Tzu-Yi
Tsai, Ming-Han
Wu, Lit-Min
Ho, Sung-Jung
Yeh, Pu-Sheng
Liu, Yi-Lien
Fred Yang, Hung-Jen
author_sort Chuang, Tzu-Yi
collection PubMed
description
format Online
Article
Text
id pubmed-7837228
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
record_format MEDLINE/PubMed
spelling pubmed-78372282021-01-26 Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19 Chuang, Tzu-Yi Tsai, Ming-Han Wu, Lit-Min Ho, Sung-Jung Yeh, Pu-Sheng Liu, Yi-Lien Fred Yang, Hung-Jen J Microbiol Immunol Infect Correspondence Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021-02 2020-10-03 /pmc/articles/PMC7837228/ /pubmed/34756359 http://dx.doi.org/10.1016/j.jmii.2020.09.007 Text en © 2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Chuang, Tzu-Yi
Tsai, Ming-Han
Wu, Lit-Min
Ho, Sung-Jung
Yeh, Pu-Sheng
Liu, Yi-Lien
Fred Yang, Hung-Jen
Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
title Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
title_full Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
title_fullStr Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
title_full_unstemmed Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
title_short Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
title_sort successful treatment of tocilizumab and ivermectin for a patient with ards due to covid-19
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837228/
https://www.ncbi.nlm.nih.gov/pubmed/34756359
http://dx.doi.org/10.1016/j.jmii.2020.09.007
work_keys_str_mv AT chuangtzuyi successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19
AT tsaiminghan successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19
AT wulitmin successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19
AT hosungjung successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19
AT yehpusheng successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19
AT liuyilien successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19
AT fredyanghungjen successfultreatmentoftocilizumabandivermectinforapatientwithardsduetocovid19